back to company universe
Developer tools

FidoCure®

Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine. FidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer. We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics. Our veterinary partners h

sources
2
Evidence entries preserved.
affiliations
2
Andreessen Horowitz, Y Combinator
competitors
6
Mapped from High Signal graph features.
status
generated
D1 lookup
last updated
2026-07-15
16:41 UTC
source evidence
Why this company exists here

Y Combinator

yc-company-directory #3858

Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine. FidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer. We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics. Our veterinary partners h

source

Andreessen Horowitz

a16z-investment-list #340
source
generated read
High Signal interpretation

FidoCure® is classified as Developer tools from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.

offline extraction
Product facets
FidoCure®veterinary medicinegenetic sequencingtargeted therapiesPrecision medicine
mapping method
Similarity graph

Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.

discovery cluster

Companies similar to FidoCure®

Developer tools · 6 peers

A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.

Yemaachi Biotechnology

match 62

Yemaachi Biotech is diversifying and expanding access to precision cancer diagnostics and therapeutics by collecting and sequencing samples from all across Africa, which is the most genetically diverse population on the planet. We then use this data to either optimize existing diagnostic tests, or help other companies discover new ones. With our research activities based in Africa, we are able to leverage access to the most genetically diverse population on the planet to build a first-of-its-kin

shared product terms: cancer, research, precision, sequenc; shared product theme: health and clinical care; shared affiliation: Y Combinator

Shield Bio

match 56

Shield Bio is a precision medicine company with a proprietary platform that enables reliable nanopore sequencing in under a minute, in a clinical setting. It is focused on bringing 3rd generation or "nanopore" sequencing into clinical use to deliver on the promise of precision medicine. Shield is initially using the technology to improve the treatment of infectious disease and address the unmet clinical need of sepsis, which kills 300,000 people a year in the US alone.

shared extracted concept terms: sequenc; shared product terms: disease, precision, medicine, bring; shared product theme: health and clinical care; shared affiliation: Andreessen Horowitz, Y Combinator

ParcelBio

match 49

ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clinical outcomes. The company is advancing programs in autoimmune disease, oncology, and encoded protein therapeutics.

shared product terms: disease, medicine, therapie, oncology; shared product theme: health and clinical care; same category: Developer tools; shared affiliation: Y Combinator

Miphic

match 49

Miphic enables the switch from long and expensive drug development to mitochondrial precision medicine that saves the lives of blood cancer patients.

shared extracted concept terms: medicine, precision; shared product terms: cancer, precision, medicine; shared product theme: health and clinical care

Meta-Flux

match 47

Meta-Flux is an AI-assisted detection diagnostics platform for disease prevention. Its Patterns and fluctuations seen in personalized medicine can identify diseases. Using Artificial Intelligence and designing computer software offers a service that ca...

shared extracted concept terms: medicine; shared product terms: disease, medicine, offer, diagnostic; shared product theme: health and clinical care

Syndicate Bio

match 44

Empowering Personalized Healthcare and Advancing Precision Medicine

shared extracted concept terms: medicine, precision; shared product terms: precision, medicine, empower